White paper on peanut allergy- part 1: Epidemiology, burden of disease, health economic aspects

Lange L, Klimek L, Beyer K, Blumchen K, Novak N, Hamelmann E, Bauer A, Merk H, Rabe U, Jung K, Schlenter W, et al. (2021)
Allergo journal international 30: 261–269.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
OA 333.07 KB
Autor*in
Lange, Lars; Klimek, Ludger; Beyer, Kirsten; Blumchen, Katharina; Novak, Natalija; Hamelmann, EckardUniBi; Bauer, Andrea; Merk, Hans; Rabe, Uta; Jung, Kirsten; Schlenter, Wolfgang; Ring, Johannes
Alle
Abstract / Bemerkung
Peanuts are Leguminosae, commonly known as the legume or pea family, and peanut allergy is among the most common food allergies and the most common cause of fatal food reactions and anaphylaxis. The prevalence of peanut allergy increased 3.5-fold over the past two decades reaching 1.4-2% in Europe and the United States. The reasons for this increase in prevalence are likely multifaceted. Sensitization via the skin appears to be associated with the development of peanut allergy and atopic eczema in infancy is associated with ahigh risk of developing peanut allergy. Until recently, the only possible management strategy for peanut allergy was strict allergen avoidance and emergency treatment including adrenaline auto-injector in cases of accidental exposure and reaction. This paper discusses the various factors that impact the risks of peanut allergy and the burden of self-management on peanut-allergic children and their caregivers. © The Author(s) 2021.
Erscheinungsjahr
2021
Zeitschriftentitel
Allergo journal international
Band
30
Seite(n)
261–269
eISSN
2197-0378
Page URI
https://pub.uni-bielefeld.de/record/2958357

Zitieren

Lange L, Klimek L, Beyer K, et al. White paper on peanut allergy- part 1: Epidemiology, burden of disease, health economic aspects. Allergo journal international. 2021;30:261–269.
Lange, L., Klimek, L., Beyer, K., Blumchen, K., Novak, N., Hamelmann, E., Bauer, A., et al. (2021). White paper on peanut allergy- part 1: Epidemiology, burden of disease, health economic aspects. Allergo journal international, 30, 261–269. https://doi.org/10.1007/s40629-021-00189-z
Lange, Lars, Klimek, Ludger, Beyer, Kirsten, Blumchen, Katharina, Novak, Natalija, Hamelmann, Eckard, Bauer, Andrea, et al. 2021. “White paper on peanut allergy- part 1: Epidemiology, burden of disease, health economic aspects”. Allergo journal international 30: 261–269.
Lange, L., Klimek, L., Beyer, K., Blumchen, K., Novak, N., Hamelmann, E., Bauer, A., Merk, H., Rabe, U., Jung, K., et al. (2021). White paper on peanut allergy- part 1: Epidemiology, burden of disease, health economic aspects. Allergo journal international 30, 261–269.
Lange, L., et al., 2021. White paper on peanut allergy- part 1: Epidemiology, burden of disease, health economic aspects. Allergo journal international, 30, p 261–269.
L. Lange, et al., “White paper on peanut allergy- part 1: Epidemiology, burden of disease, health economic aspects”, Allergo journal international, vol. 30, 2021, pp. 261–269.
Lange, L., Klimek, L., Beyer, K., Blumchen, K., Novak, N., Hamelmann, E., Bauer, A., Merk, H., Rabe, U., Jung, K., Schlenter, W., Ring, J., Chaker, A., Wehrmann, W., Becker, S., Mulleneisen, N., Nemat, K., Czech, W., Wrede, H., Brehler, R., Fuchs, T., Jakob, T., Ankermann, T., Schmidt, S.M., Gerstlauer, M., Zuberbier, T., Spindler, T., Vogelberg, C.: White paper on peanut allergy- part 1: Epidemiology, burden of disease, health economic aspects. Allergo journal international. 30, 261–269 (2021).
Lange, Lars, Klimek, Ludger, Beyer, Kirsten, Blumchen, Katharina, Novak, Natalija, Hamelmann, Eckard, Bauer, Andrea, Merk, Hans, Rabe, Uta, Jung, Kirsten, Schlenter, Wolfgang, Ring, Johannes, Chaker, Adam, Wehrmann, Wolfgang, Becker, Sven, Mulleneisen, Norbert, Nemat, Katja, Czech, Wolfgang, Wrede, Holger, Brehler, Randolf, Fuchs, Thomas, Jakob, Thilo, Ankermann, Tobias, Schmidt, Sebastian M, Gerstlauer, Michael, Zuberbier, Torsten, Spindler, Thomas, and Vogelberg, Christian. “White paper on peanut allergy- part 1: Epidemiology, burden of disease, health economic aspects”. Allergo journal international 30 (2021): 261–269.
Alle Dateien verfügbar unter der/den folgenden Lizenz(en):
Creative Commons Namensnennung 4.0 International Public License (CC-BY 4.0):
Volltext(e)
Access Level
OA Open Access
Zuletzt Hochgeladen
2023-08-14T12:46:53Z
MD5 Prüfsumme
4cd3a693b9d1373443ad1f901873ec01


Link(s) zu Volltext(en)
Access Level
OA Open Access

Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

References

Daten bereitgestellt von Europe PubMed Central.

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®
Quellen

PMID: 34603938
PubMed | Europe PMC

Suchen in

Google Scholar